Location History:
- Geneva, CH (2020)
- Chancy, CH (2022)
Company Filing History:
Years Active: 2020-2022
Title: Doron Merkler: Innovator in Neurodegenerative Disease Treatment
Introduction
Doron Merkler is a prominent inventor based in Geneva, Switzerland. He has made significant contributions to the field of medical research, particularly in the treatment and prevention of neurodegenerative diseases. With a total of 2 patents, his work focuses on innovative methods and compounds that aim to improve patient outcomes.
Latest Patents
Merkler's latest patents include a groundbreaking method for treating or preventing neurodegeneration. This invention relates to a compound that effectively inhibits the function of the TRPM4 ion channel. The use of this compound is aimed at treating or preventing neurodegenerative diseases such as Multiple Sclerosis, Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis. Additionally, the invention provides a pharmaceutical composition that includes a TRPM4 inhibitory compound. Another notable patent involves tri-segmented arenaviruses as vaccine vectors. This application describes arenaviruses with rearrangements of their open reading frames in their genomes. The modified arenavirus genomic segment is engineered to carry a viral open reading frame in a position different from its wild-type position. These trisegmented arenavirus particles may be suitable for vaccines, treatment of diseases, and immunotherapies.
Career Highlights
Doron Merkler has worked with esteemed institutions such as Université De Genève and Reprise Pharmaceuticals, Inc. His career reflects a commitment to advancing medical science and developing innovative solutions for complex health issues.
Collaborations
Merkler has collaborated with notable professionals in his field, including Daniel David Pinschewer and Sandra Margarete Kallert. These collaborations have further enriched his research and contributed to the development of his patents.
Conclusion
Doron Merkler stands out as an influential inventor in the realm of neurodegenerative disease treatment. His innovative patents and collaborations highlight his dedication to improving healthcare through scientific advancements.